Nitric oxide vs insulin secretion, action and clearance

被引:0
作者
Olga Kruszelnicka
机构
[1] The John Paul II Hospital in Kraków,Department of Coronary Artery Disease
来源
Diabetologia | 2014年 / 57卷
关键词
Asymmetric dimethylarginine; Insulin clearance; Insulin resistance; Insulin secretion; Nitric oxide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:257 / 258
页数:1
相关论文
共 43 条
[1]  
Natali A(2013)Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion Diabetologia 56 1183-1191
[2]  
Ribeiro R(2000)Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance Diabetes 49 684-687
[3]  
Baldi S(2004)Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus JAMA 291 1978-1986
[4]  
Shankar RR(2008)Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension Diabetes 57 167-171
[5]  
Wu Y(2007)Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus J Intern Med 261 392-398
[6]  
Shen HQ(2013)Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study Cardiovasc Diabetol 12 64-1868
[7]  
Zhu JS(2013)What do we learn from measurements of HOMA-IR? Diabetologia 56 1867-1073
[8]  
Baron AD(2009)Nitric oxide inhibits insulin-degrading enzyme activity and function through Biochem Pharmacol 77 1064-315
[9]  
Meigs JB(2012)-nitrosylation Curr Diabetes Rev 8 303-36166
[10]  
Hu FB(2009)The good and bad effects of cysteine S-nitrosylation and tyrosine nitration upon insulin exocytosis: a balancing act J Biol Chem 284 36160-644